Docusign (NASDAQ:DOCU) Insider James Shaughnessy Sells 12,000 Shares

Docusign Inc. (NASDAQ:DOCU) insider James Shaughnessy sold 12,000 shares of Docusign stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total value of $546,480.00. Following the sale, the insider directly owned 52,815 shares in the company, valued at $2,405,195.10. The trade was a 18.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Price Performance

Shares of DOCU traded up $1.60 during mid-day trading on Wednesday, reaching $46.02. The company had a trading volume of 3,492,477 shares, compared to its average volume of 4,953,224. Docusign Inc. has a twelve month low of $40.16 and a twelve month high of $86.65. The company’s 50-day moving average is $46.93 and its 200-day moving average is $51.11. The company has a market capitalization of $8.79 billion, a P/E ratio of 29.88, a P/E/G ratio of 1.31 and a beta of 0.90.

Docusign (NASDAQ:DOCU) last announced its quarterly earnings results on Thursday, June 4th. The company reported $1.09 EPS for the quarter, beating the consensus estimate of $0.99 by $0.10. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The business had revenue of $830.24 million for the quarter, compared to analyst estimates of $824.71 million. During the same quarter in the previous year, the firm earned $0.90 EPS. Docusign’s quarterly revenue was up 8.7% on a year-over-year basis. As a group, equities analysts expect that Docusign Inc. will post 2.03 EPS for the current fiscal year.

Docusign declared that its Board of Directors has initiated a share buyback plan on Tuesday, March 17th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to repurchase up to 21% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s board believes its shares are undervalued.

Institutional Investors Weigh In On Docusign

A number of institutional investors and hedge funds have recently added to or reduced their stakes in DOCU. Central Pacific Bank Trust Division bought a new position in Docusign during the 4th quarter worth approximately $25,000. Modus Advisors LLC bought a new position in shares of Docusign during the fourth quarter worth $27,000. Torren Management LLC bought a new position in shares of Docusign during the fourth quarter worth $28,000. True Wealth Design LLC grew its holdings in shares of Docusign by 105.2% in the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock valued at $30,000 after buying an additional 222 shares during the period. Finally, Aventura Private Wealth LLC bought a new position in Docusign during the fourth quarter worth about $30,000. Institutional investors own 77.64% of the company’s stock.

Key Stories Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate for Docusign to $1.69 from $1.53, suggesting stronger expected profitability over the next couple of years.
• Positive Sentiment: The firm also increased its FY2028 EPS estimate to $1.76 from $1.89, and lifted Q1 2028 EPS to $0.47 from $0.45, reinforcing a more favorable near-to-midterm earnings view.
• Positive Sentiment: Analysts boosted Q4 2028 EPS to $0.62 from $0.59 and Q1 2029 EPS to $0.73 from $0.51, indicating continued expectation for earnings growth further out. Docusign estimate revisions
• Neutral Sentiment: Not all revisions were positive: Zacks trimmed Q2 2028 EPS to $0.28 from $0.43, Q3 2028 EPS to $0.38 from $0.41, and FY2029 EPS to $1.35 from $2.10, showing a mixed long-range outlook.
• Neutral Sentiment: The current-year consensus estimate remains around $1.97 per share, so the latest changes mainly affect longer-dated forecasts rather than near-term results.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Robert W. Baird reduced their price objective on Docusign from $75.00 to $55.00 and set a “neutral” rating on the stock in a report on Wednesday, March 18th. Weiss Ratings cut Docusign from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, June 26th. Piper Sandler dropped their target price on Docusign from $75.00 to $52.00 and set a “neutral” rating for the company in a research report on Wednesday, March 18th. Jefferies Financial Group upped their price target on Docusign from $45.00 to $50.00 and gave the company a “hold” rating in a research note on Friday, June 5th. Finally, UBS Group set a $60.00 price objective on Docusign in a research report on Friday, June 5th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $60.27.

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.